Pzena Investment Management LLC Sells 753,790 Shares of Humana Inc. $HUM

Pzena Investment Management LLC reduced its position in Humana Inc. (NYSE:HUM) by 17.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,649,346 shares of the insurance provider’s stock after selling 753,790 shares during the quarter. Humana makes up approximately 4.1% of Pzena Investment Management LLC’s portfolio, making the stock its 3rd biggest position. Pzena Investment Management LLC owned 3.04% of Humana worth $1,392,481,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of HUM. BlackRock Inc. purchased a new position in Humana during the 2nd quarter worth approximately $4,138,160,000. Assenagon Asset Management S.A. grew its position in shares of Humana by 20,126.8% in the third quarter. Assenagon Asset Management S.A. now owns 1,255,479 shares of the insurance provider’s stock valued at $479,053,000 after purchasing an additional 1,249,272 shares during the last quarter. Legal & General Group Plc acquired a new position in Humana in the 2nd quarter valued at about $329,760,000. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in shares of Humana during the second quarter valued at approximately $314,922,000. Finally, Wellington Management Group LLP increased its stake in shares of Humana by 7.3% during the 2nd quarter. Wellington Management Group LLP now owns 765,355 shares of the insurance provider’s stock valued at $304,014,000 after acquiring an additional 52,004 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

HUM has been the subject of a number of research reports. Wells Fargo & Company raised shares of Humana from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $227.00 to $502.00 in a research report on Monday, July 13th. Wolfe Research reissued an “outperform” rating and set a $450.00 target price on shares of Humana in a research note on Monday, August 24th. Guggenheim raised their price objective on Humana from $269.00 to $471.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Wall Street Zen lowered Humana from a “buy” rating to a “hold” rating in a report on Sunday. Finally, Barclays upped their price target on Humana from $515.00 to $582.00 and gave the stock an “overweight” rating in a research note on Friday, October 9th. Twenty-one equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $453.30.

Humana Stock Performance

Shares of Humana stock opened at $417.32 on Thursday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $456.50. The firm has a market cap of $50.11 billion, a P/E ratio of 39.48, a P/E/G ratio of 2.57 and a beta of 0.65. The firm has a 50 day simple moving average of $402.73 and a 200 day simple moving average of $310.76.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 24th will be issued a $0.8850 dividend. The ex-dividend date of this dividend is Thursday, December 24th. This represents a $3.54 annualized dividend and a dividend yield of 0.8%. Humana’s payout ratio is 33.49%.

About Humana

Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company’s primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.

Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.

Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.